Skip to main content

Advertisement

Log in

Human papillomavirus prevalence among men who have sex with men in China: a systematic review and meta-analysis

  • Review
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Human papillomavirus (HPV) infection among men who have sex with men (MSM) in China is underreported. We performed a systematic review and meta-analysis to clarify site-specific HPV prevalence among MSM in China. We searched both English and Chinese databases for all studies published before April 1, 2020, that reported HPV prevalence among MSM in China. Random-effects meta-analysis was used to calculate summary estimates. Thirty-four articles were eligible, where 32, 5, and 2 articles reported HPV prevalence at the anus, penis, and oral cavity, respectively. The estimated prevalence of anal HPV among MSM in China was 85.1% (HIV-positive), 53.6% (HIV-negative), and 59.2% (unknown HIV status), with HPV genotypes being predominated by HPV 6, 11, 16, 18, 52, and 58. Any HPV and high-risk (HR) HPV was more common in northern China, while low-risk HPV was more common in southern China. HPV prevalence increased with age among HIV-negative MSM, from 40.5% (aged < 20 years) to 57.2% (aged ≥ 40 years). High prevalence of any HPV (HIV+: 95.1%; HIV−: 97.7%) and multiple infections (HIV+: 75.9%; HIV−: 41.7%) was found in anogenital warts among MSM. HPV is common among MSM in China. MSM living with HIV and/or anogenital warts were at disproportionate risk for HR HPV. Younger MSM were found to have a lower HPV prevalence. HPV vaccines would have prevented the majority of infections if given before sex debut. HPV at anatomical sites other than the anus, incident HPV infection, and the cost-effectiveness of HPV vaccination in this population are worth further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article and its supplementary files.

References

  1. Trottier H, Franco EL (2006) The epidemiology of genital human papillomavirus infection. Vaccine 24(Suppl 1):S1–S15. https://doi.org/10.1016/j.vaccine.2005.09.054

    Article  PubMed  Google Scholar 

  2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19.

  3. Koutsky L (1997) Epidemiology of genital human papillomavirus infection. Am J Med 102(5 PART A):3–8

    Article  CAS  Google Scholar 

  4. Chaturvedi AK (2010) Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health 46(4 Suppl):S20–S26. https://doi.org/10.1016/j.jadohealth.2010.01.016

    Article  PubMed  Google Scholar 

  5. Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, Barr E, Haupt RM, Joura EA (2009) Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) Vaccine. J Infect Dis 199(6):805–814. https://doi.org/10.1086/597071

    Article  PubMed  Google Scholar 

  6. Goldstone S, Palefsky JM, Giuliano AR, Moreira ED, Aranda C, Jessen H, Hillman RJ, Ferris DG, Coutlee F, Liaw KL, Marshall JB, Zhang X, Vuocolo S, Barr E, Haupt RM, Guris D, Garner EI (2011) Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis 203(1):66–74. https://doi.org/10.1093/infdis/jiq016

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ma X, Wang Q, Ong JJ, Fairley CK, Su S, Peng P, Jing J, Wang L, Soe NN, Cheng F, Zhang L (2018) Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis. Sex Transm Infect 94(6):434–442. https://doi.org/10.1136/sextrans-2017-053412

    Article  PubMed  Google Scholar 

  8. Marra E, Lin C, Clifford GM (2019) Type-specific anal human papillomavirus prevalence among men, according to sexual preference and hiv status: a systematic literature review and meta-analysis. J Infect Dis 219(4):590–598. https://doi.org/10.1093/infdis/jiy556

    Article  CAS  PubMed  Google Scholar 

  9. de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7(7):453–459. https://doi.org/10.1016/s1473-3099(07)70158-5

    Article  PubMed  Google Scholar 

  10. Looker KJ, Rönn MM, Brock PM, Brisson M, Drolet M, Mayaud P, Boily MC (2018) Evidence of synergistic relationships between HIV and human papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. J Int AIDS Soc 21(6):e25110. https://doi.org/10.1002/jia2.25110

    Article  PubMed  PubMed Central  Google Scholar 

  11. Mooij SH, Boot HJ, Speksnijder AG, Stolte IG, Meijer CJ, Snijders PJ, Verhagen DW, King AJ, de Vries HJ, Quint WG, van der Sande MA, Schim van der Loeff MF (2013) Oral human papillomavirus infection in HIV-negative and HIV-infected MSM. Aids 27(13):2117–2128. https://doi.org/10.1097/QAD.0b013e328362395c

    Article  PubMed  Google Scholar 

  12. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, Templeton DJ, Grulich AE (2012) Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 13(5):487–500. https://doi.org/10.1016/s1470-2045(12)70080-3

    Article  PubMed  Google Scholar 

  13. World Health Organization. Major milestone reached as 100 countries have introduced HPV vaccine into national schedule. Available at: https://www.who.int/news-room/detail/31-10-2019-major-milestone-reached-as-100-countries-have-introduced-hpv-vaccine-into-national-schedule. Verified on: June 22, 2020

  14. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D (2011) Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 364(5):401–411. https://doi.org/10.1056/NEJMoa0909537

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, Hillman R, Ferris D, Coutlee F, Stoler MH, Marshall JB, Radley D, Vuocolo S, Haupt RM, Guris D, Garner EI (2011) HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 365(17):1576–1585. https://doi.org/10.1056/NEJMoa1010971

    Article  CAS  PubMed  Google Scholar 

  16. Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Regan DG, Hocking JS, Garland SM, Cornall AM, Atchison S, Bradshaw CS, McNulty A, Owen L, Marshall L, Russell DB, Kaldor JM, Chen MY (2019) Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017. Vaccine 37(46):6907–6914. https://doi.org/10.1016/j.vaccine.2019.09.052

    Article  PubMed  Google Scholar 

  17. Pollock KG, Wallace LA, Wrigglesworth S, McMaster D, Steedman N (2019) HPV vaccine uptake in men who have sex with men in Scotland. Vaccine 37(37):5513–5514. https://doi.org/10.1016/j.vaccine.2018.11.081

    Article  CAS  PubMed  Google Scholar 

  18. Cheng S-H, Chu F-Y, Lin Y-S, Hsueh Y-M (2012) Influence of age and CD4+ T cell counts on the prevalence of genital human papillomavirus infection among HIV-seropositive men who have sex with men in Taiwan. J Med Virol 84(12):1876–1883. https://doi.org/10.1002/jmv.23413

    Article  PubMed  Google Scholar 

  19. Fan J, Zhao M, Gui X, Qiu H, Wang L, Zhang Y (2018) Effect of combined antiretroviral therapy on the prevalence of anal human papillomavirus infection in human immunodeficiency virus-infected men who have sex with men (Effect of combined antiretroviral therapy on the prevalence of anal human papillomavirus infection in human immunodeficiency virus-infected men who have sex with men). Chin J Infect Dis 36(12)

  20. Strong C, Zou H, Ko N-Y, Liang Y-L, Ku W-W, Lee C-W (2019) Prevalence and risk factors of anogenital human papillomavirus infection in a community sample of men who have sex with men in Taiwan: baseline findings from a cohort study. Sex Transm Infect. https://doi.org/10.1136/sextrans-2018-053629

  21. Zhou Y, Lin Y-F, Meng X, Duan Q, Wang Z, Yang B, Zheng H, Li P, Li M, Lu Y, Luo Z, Zou H (2020) Anal human papillomavirus among men who have sex with men in three metropolitan cities in southern China: implications for HPV vaccination. Vaccine 38(13):2849–2858. https://doi.org/10.1016/j.vaccine.2020.02.009

    Article  PubMed  Google Scholar 

  22. Zou H, Zhang L, Puifung CE, Zhang L (2014) Teenage men who have sex with men should be vaccinated against human papillomavirus infection. Zhonghua Liu Xing Bing Xue Za Zhi 35(9):1072–1073

    PubMed  Google Scholar 

  23. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ-Br Med J 339:37. https://doi.org/10.1136/bmj.b2700

    Article  Google Scholar 

  24. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, Grp M (2000) Meta-analysis of observational studies in epidemiology - a proposal for reporting. JAMA-J Am Med Assoc 283(15):2008–2012. https://doi.org/10.1001/jama.283.15.2008

    Article  CAS  Google Scholar 

  25. Baidupedia, Chinese geographical division. Available at https://baike.baidu.com/item/%E4%B8%AD%E5%9B%BD%E5%9C%B0%E7%90%86%E5%8C%BA%E5%88%92. Verified on: July 24, 2020.

  26. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17–27. https://doi.org/10.1016/j.virol.2004.03.033

    Article  CAS  PubMed  Google Scholar 

  27. Aromataris E, Munn Z (Eds) (2020) JBI Reviewer’s Manual. JBI. Available at https://reviewersmanual.joannabriggs.org/. Verified on: June 24, 2020

  28. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T (2013) Meta-analysis of prevalence. J Epidemiol Commun Health 67(11):974–978

    Article  Google Scholar 

  29. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11(2):193–206. https://doi.org/10.1037/1082-989x.11.2.193

  30. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634. https://doi.org/10.1136/bmj.315.7109.629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53(11):1119–1129. https://doi.org/10.1016/s0895-4356(00)00242-0

    Article  CAS  PubMed  Google Scholar 

  32. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 64(11):300–304

    PubMed  PubMed Central  Google Scholar 

  33. Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ (2013) Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Bmj 346:f2032. https://doi.org/10.1136/bmj.f2032

    Article  PubMed  Google Scholar 

  34. Lukács A, Máté Z, Farkas N, Mikó A, Tenk J, Hegyi P, Németh B, Czumbel LM, Wuttapon S, Kiss I, Gyöngyi Z, Varga G, Rumbus Z, Szabó A (2020) The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis. BMC Public Health 20(1):691. https://doi.org/10.1186/s12889-020-08753-y

    Article  PubMed  PubMed Central  Google Scholar 

  35. Malagón T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M (2012) Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12(10):781–789. https://doi.org/10.1016/s1473-3099(12)70187-1

    Article  PubMed  Google Scholar 

  36. Kelly H, Chikandiwa A, Alemany Vilches L, Palefsky JM, de Sanjose S, Mayaud P (2020) Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis. Lancet HIV 7(4):e262–e278. https://doi.org/10.1016/s2352-3018(19)30434-5

    Article  PubMed  Google Scholar 

  37. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH (1999) Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37(10):3316–3322

    Article  CAS  Google Scholar 

  38. Health Promotion Administration, Ministry of Health and Welfare. Can only girls get HPV vaccine? Available at https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=127&pid=8160. Verified on: July 3, 2020

  39. Breese PL, Judson FN, Penley KA, Douglas JM (1995) Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus. Sex Transm Dis 22(1)

  40. Vajdic CM, van Leeuwen MT, Jin F, Prestage G, Medley G, Hillman RJ, Stevens MP, Botes LP, Zablotska I, Tabrizi SN, Grulich AE (2009) Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect 85(5):330–335. https://doi.org/10.1136/sti.2008.034744

    Article  CAS  PubMed  Google Scholar 

  41. Chin-Hong PV, Vittinghoff E, Cranston RD, Buchbinder S, Cohen D, Colfax G, Da Costa M, Darragh T, Hess E, Judson F, Koblin B, Madison M, Palefsky JM (2004) Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis 190(12):2070–2076. https://doi.org/10.1086/425906

    Article  PubMed  Google Scholar 

  42. Zou H, Xu J, Hu Q, Yu Y, Fu G, Wang Z, Lu L, Zhuang M, Chen X, Fu J, Zhou Z, Geng W, Jiang Y, Shang H (2016) Decreasing age at first anal intercourse among men who have sex with men in China: a multicentre cross-sectional survey. J Int AIDS Soc 19(1):20792. https://doi.org/10.7448/IAS.19.1.20792

    Article  PubMed  PubMed Central  Google Scholar 

  43. González C, Torres M, Benito A, Del Romero J, Rodríguez C, Fontillón M, Trastoy M, Viciana P, Del Amo J, Ortiz M, Hernández-Novoa B (2013) Anal squamous intraepithelial lesions are frequent among young HIV-infected men who have sex with men followed up at the Spanish AIDS Research Network Cohort (CoRIS-HPV). Int J Cancer 133(5):1164–1172. https://doi.org/10.1002/ijc.28102

    Article  CAS  PubMed  Google Scholar 

  44. Qian H-Z, Hu Y, Carlucci JG, Yin L, Li X, Giuliano AR, Li D, Gao L, Shao Y, Vermund SH (2017) Human immunodeficiency virus status differentially associated with genital and anal human papillomavirus infection among Chinese men who have sex with men: a cross-sectional survey. Sex Transm Dis 44(11):656–662. https://doi.org/10.1097/olq.0000000000000672

    Article  PubMed  PubMed Central  Google Scholar 

  45. Chen X, Yu J, Li M, Su Q (2011) Survey on infection of HPV and HIV among men who have sex with men in Beijing (Survey on infection of HPV and HIV among men who have sex with men in Beijing). Int J Virol 18(4)

Download references

Acknowledgements

We thank the following authors for sharing their data: Shu-Hsing Cheng (Taipei Medical University, Taipei, Taiwan); Lei Gao (Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China); Jiangping Sun (Chinese Center for Disease Control and Prevention, Beijing, China); Qi Jin (Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China); Han-Zhu Qian (Vanderbilt University School of Medicine, Nashville, USA); Jianghong Dai (Xinjiang Medical University, Urumqi, China); Lanying Li (Shanghai Jiao Tong University, Shanghai, China); Yongxi Zhang (Zhongnan Hospital of Wuhan University, Wuhan, China); Xiaohui Zhang (Guangdong Provincial Dermatology Hospital, Guangzhou, China); and Song Fan (Sun Yat-sen University, Guangzhou, China).

Funding

This study was supported by the Natural Science Foundation of China Excellent Young Scientists Fund [82022064], the Natural Science Foundation of China International/Regional Research Collaboration Project [72061137001], the Natural Science Foundation of China Young Scientist Fund [81703278], the Australian National Health and Medical Research Commission (NHMRC) Early Career Fellowship [APP1092621], the National Science and Technology Major Project of China [2018ZX10721102], the Sanming Project of Medicine in Shenzhen [SZSM201811071], the High Level Project of Medicine in Longhua, Shenzhen [HLPM201907020105], and the National Key Research and Development Program of China [2020YFC0840900]. All funding parties did not have any role in the design of the study or in the explanation of the data.

Author information

Authors and Affiliations

Authors

Contributions

This study was conceived and designed by HZ and YZ in consultation with the other authors. YZ and YL were responsible for study retrieval and screening. YZ, TY, and PL were responsible for data compilation and data analysis. All authors have contributed to interpretation of data and study findings. YZ, YL, and GL drafted the manuscript with all authors critically reviewing the paper.

Ethics declarations

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publish

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 302 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Y., Lin, YF., Gao, L. et al. Human papillomavirus prevalence among men who have sex with men in China: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 40, 1357–1367 (2021). https://doi.org/10.1007/s10096-021-04229-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-021-04229-y

Keywords

Navigation